Dr Yagiz Alp Aksoy is a Senior Research Fellow at the Daffodil Centre and Senior Clinical Research Fellow at the Biomedical AI Centre, Centenary Institute. He is a clinician-researcher whose work sits at the intersection of artificial intelligence, clinical medicine, and health policy. His current research focuses on AI-enabled cancer detection and risk stratification, with a particular emphasis on melanoma and skin cancer. He contributes to Australia’s National Targeted Skin Cancer Screening Roadmap, leading evidence synthesis on risk prediction tools, AI-assisted screening, and workforce integration. He has secured over $4M in competitive research funding as Chief Investigator, including an Australian Economic Accelerator Ignite grant to develop a clinically deployed AI platform for precision oncology decision support, and an NHMRC Partnership Grant for ethical governance of AI in healthcare (REP-AI).
Yagiz holds an MD from the University of Sydney and a PhD in biomedical sciences from Macquarie University. He brings six years of senior health policy experience from the NSW Ministry of Health, where he led the state’s research ethics, governance, and clinical trials portfolio, including developing the early phase clinical trials framework. He is an Honorary Dermatology Registrar at Prince of Wales Hospital and his work within a national multi-site melanoma imaging collaboration applies machine learning to evaluate the incremental value of image-derived biomarkers in clinical risk prediction. His research vision centres on building and evaluating AI tools that are clinically valid, equitably deployed, and implementation-ready.